laufenden Studien - Uro-Onkologie und Prostatazentrum

Universitäres Zentrum für Uro-Onkologie
am Inselspital Bern
Studienliste
Liste
Studie
Entität
Klinik
Principal
investigator
Co-investigator
Verantwortliche
study nurse
SV study nurse
Datum Start
Datum Ende
Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage
IIA/B Seminoma (SAKK 01/10)
Hodentumor
(Seminom)
Radioonkologie,
Med. Onkologie
Aebersold
Alan Dal Pra
S. Fuchser (Rad
Onc)
T. Nannen (Rad
Onc)
Q 2/2012
Mit
FUP
11/2035
A randomized phase III trial comparing
conventional-dose chemotherapy using
paclitaxel, ifosfamide, and cisplatin (tip)
with high-dose chemotherapy using
mobilizing paclitaxel plus ifosfamide
followed by high-dose carboplatin and
etoposide (ti-ce) as first salvage treatment in relapsed or refractory germ cell
tumors
Hodentumor
Med. Onkologie
Zweifel
n.a.
n.a.
Planned
Q3/2016
A Randomized Multicenter Phase III
Trial Comparing Enzalutamide vs. a
Combination of Ra223 and Enzalutamide in Asymptomatic or Mildly Symptomatic Castration Resistant Prostate
Cancer Patients Metastatic to Bone
(PEACE III)
Prostatakarzinom
Urologie/
Spahn
Klaeser
(Nuklearmed)
Fr. Tschan
Q1/2016
STAMPEDE: Systemic Therapy in
Advancing or Metastatic Prostate
Cancer: Evaluation of Drug Efficacy: A
Multi-Stage Multi-Arm Randomised
Controlled Trial
Prostatakarzinom
Urologie
Thalmann
Roth
Fr.
Ochsner
Nannen,
Timo (Rad Onc)
December
2005
Reproduzierbarkeit von ADC-Werten
gemessen in MRT-Systemen unterschiedlicher
Hersteller
(General
Prostata
Radiologie
Urologie
Thoeny
Barbieri,
n.a.
Q3 2016
Nuklearmedizin
/
Thalmann, Boxler
Patientenzahl pro
Kalenderjahr
bis
1-2
open
September 2017
open
30
[Geben Sie Text ein]
Electrics®, Philips® und Siemens®)
und verschiedener Magnetfeldstärken
(1.5 und 3.0 Tesla)
KEK-Gesuch Nr. 070/10
PRECISION: A randomised controlled
trial of magnetic resonance imagingtargeted biopsy compared to standard
trans-rectal ultrasound guided biopsy
for the diagnosis of prostate cancer in
men without prior biopsy.
Prostatakarzinom
Urologie/Radiologie
Boxler
SAKK 06/14: rekombinantes BCG bei
Rezidiv nicht-invasivem Urothelkarzinom der Harnblase
Blasenkarzinom
Urologie
Thalmann
Dose intensified salvage radiotherapy in
biochemically relapsed prostate cancer
without macroscopic disease. A randomized phase III trial (SAKK 09/10)
Prostata
UKRO
PROMET - Multicenter, Randomized,
Double Blind, Placebo Controlled
Phase II Trial of Salvage Radiotherapy
+/- Metformin for Prostate Cancer after
Prostatectomy (SAKK08/15)
Prostatakarzinom
SAKK 63/12 - Prospective cohort study
with collection of clinical data and
serum of patients with prostate disease
Prostatakarzinom
Uro-Onko_Studienliste_2016
Tschan, Nathalie
International
Start 02/2016,
lokal Warten
auf
Ethik
approval
(voraussichtlich 08/2016)
12/2017
open
Roth, Kiss
Fr. Ochsner, Fr.
Tschan
07/2015
2023
Total 45 Patienten
geplant
Dal Pra
-----
Dorn
-----
15.01.2011
01.04.2014
noch aktiv)
URKO
Dal Pra
----
Nannen
--------
01/01/2017
(estimate)
Urologie/UKRO
Thalmann
Dal Pra
Hermann/Fuchser
Genehmigt durch: Spahn, DelPra,
Schardt, Ochsner
13/01/2015
Datum:2016
(FUP

Download Report